A Study of LY2140023 in Healthy Participants

This study has been withdrawn prior to enrollment.
(The decision to stop the trial was based on efficacy results in the overall schizophrenia patient population.)
Sponsor:
Information provided by (Responsible Party):
Eli Lilly and Company
ClinicalTrials.gov Identifier:
NCT01659177
First received: August 3, 2012
Last updated: September 28, 2012
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: September 2012
  Estimated Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)